Effects of the COVID-19 pandemic on surgical treatment for thoracic malignant tumor cases in Japan: a national clinical database analysis

Shintani, Yasushi; Yamamoto, Hiroyuki; Sato, Yukio; Inoue, Masayoshi; Asakura, Keisuke; Ito, Hiroyuki; Uramoto, Hidetaka; Okada, Yoshinori; Sato, Toshihiko; Fukui, Mariko; Hoshikawa, Yasushi; Yoshikawa, Toyofumi Fengshi Chen; Chida, Masayuki; Ikeda, Norihiko; Yoshino, Ichiro

doi:https://doi.org/10.1007/s00595-024-02907-w

Effects of the COVID-19 pandemic on surgical treatment for thoracic malignant tumor cases in Japan: a national clinical database analysis

Shintani, Yasushi; Yamamoto, Hiroyuki; Sato, Yukio et al.

Surgery Today, 2024

Number of Access:1,802（2025-08-21 17:19 Counts）

Identifier to cite or link to this item: https://hdl.handle.net/11094/98913

Link to primary information

File	Format	Terms of use	Size	Views	Date.Available	Description	information
SurgToday_s00595-024-02907-w	pdf	None	1.03 MB	26	2025.01.06

Creative Commons : Attribution

Item Information

Output File Export EndNote Basic Export Mendeley

Title	Effects of the COVID-19 pandemic on surgical treatment for thoracic malignant tumor cases in Japan: a national clinical database analysis
Creator	NRID 1000090572983 1000090572983 researchmap permalink shintani6384 shintani6384 Scopus Author ID 7103142734 7103142734 CreatorName Shintani, Yasushi
	NRID 1000080528852 1000080528852 CreatorName Yamamoto, Hiroyuki
	NRID 1000010312844 1000010312844 CreatorName Sato, Yukio
	NRID 1000010379232 1000010379232 CreatorName Inoue, Masayoshi
	NRID 1000090383786 1000090383786 CreatorName Asakura, Keisuke
	CreatorName Ito, Hiroyuki
	NRID 1000090389445 1000090389445 CreatorName Uramoto, Hidetaka
	NRID 1000090323104 1000090323104 CreatorName Okada, Yoshinori
	NRID 1000040388822 1000040388822 CreatorName Sato, Toshihiko
	NRID 1000090621962 1000090621962 CreatorName Fukui, Mariko
	NRID 1000090333814 1000090333814 CreatorName Hoshikawa, Yasushi
	NRID 1000000452334 1000000452334 CreatorName Yoshikawa, Toyofumi Fengshi Chen
	NRID 1000070333812 1000070333812 CreatorName Chida, Masayuki
	NRID 1000070246205 1000070246205 CreatorName Ikeda, Norihiko
	NRID 1000040281547 1000040281547 CreatorName Yoshino, Ichiro
Subject	COVID-19
	Lung cancer
	Mediastinal tumor
Description	The version of record of this article, first published in Surgery Today, is available online at Publisher’s website: https://doi.org/10.1007/s00595-024-02907-w.
Abstract	Objective: Surgical care has been significantly affected by the COVID-19 pandemic. This study was conducted to evaluate the effects of the pandemic on lung cancer and mediastinal tumor surgery. Methods: Changes in the number of surgical procedures for lung cancer and mediastinal tumors were analyzed using the National Clinical Database of Japan. Patient characteristics, including disease stage and histological type, from 2019 to 2022 were evaluated using annual datasets. Results: Comparisons with 2019 showed that the number of patients who underwent surgery for primary lung cancer or a mediastinal tumor decreased in 2020 and then remained stable. There were no clinically significant changes in the trend over the four-year period regarding the number of patients for each clinical and pathological stage of lung cancer. Regarding mediastinal tumors, there was no significant difference in tumor size between years. There was a slight change in the selection of surgical indication during the second quarter of 2020, although its impact on annual trends in the stage distribution for lung cancer and primary disease for mediastinal tumors was minimal. Conclusions: Analyses of lung cancer and mediastinal tumor surgery cases in Japan during the COVID-19 pandemic showed no significant disease profile changes related to treatment delay.
Publisher	Springer
Source Title	Surgery Today
Date of Issued	2024-12-07
Language	English
Handle URL	https://hdl.handle.net/11094/98913
PISSN	09411291
eISSN	14362813
Relation.isIdenticalTo	DOI (Publisher Version) https://doi.org/10.1007/s00595-024-02907-w
Access Rights	open access
CopyRight	This article is licensed under a Creative Commons Attribution 4.0 International License.
oaire:version	Version of Record
Category	学術雑誌論文 Journal Article

Resource Type	journal article
Local Type	Journal Article
DCTERMS.bibliographicCitation	Surgery Today. 2024
DC.title	Effects of the COVID-19 pandemic on surgical treatment for thoracic malignant tumor cases in Japan: a national clinical database analysis
DC.creator	Shintani, Yasushi
	Yamamoto, Hiroyuki
	Sato, Yukio
	Inoue, Masayoshi
	Asakura, Keisuke
	Ito, Hiroyuki
	Uramoto, Hidetaka
	Okada, Yoshinori
	Sato, Toshihiko
	Fukui, Mariko
	Hoshikawa, Yasushi
	Yoshikawa, Toyofumi Fengshi Chen
	Chida, Masayuki
	Ikeda, Norihiko
	Yoshino, Ichiro
DC.publisher	Springer
DC.language' scheme='DCTERMS.RFC1766	English
DCTERMS.issued' scheme='DCTERMS.W3CDTF	2024-12-07
DC.identifier	https://doi.org/10.1007/s00595-024-02907-w
DC.subject	COVID-19
	Lung cancer
	Mediastinal tumor
DC.description	The version of record of this article, first published in Surgery Today, is available online at Publisher’s website: https://doi.org/10.1007/s00595-024-02907-w.
DCTERMS.abstract	Objective: Surgical care has been significantly affected by the COVID-19 pandemic. This study was conducted to evaluate the effects of the pandemic on lung cancer and mediastinal tumor surgery. Methods: Changes in the number of surgical procedures for lung cancer and mediastinal tumors were analyzed using the National Clinical Database of Japan. Patient characteristics, including disease stage and histological type, from 2019 to 2022 were evaluated using annual datasets. Results: Comparisons with 2019 showed that the number of patients who underwent surgery for primary lung cancer or a mediastinal tumor decreased in 2020 and then remained stable. There were no clinically significant changes in the trend over the four-year period regarding the number of patients for each clinical and pathological stage of lung cancer. Regarding mediastinal tumors, there was no significant difference in tumor size between years. There was a slight change in the selection of surgical indication during the second quarter of 2020, although its impact on annual trends in the stage distribution for lung cancer and primary disease for mediastinal tumors was minimal. Conclusions: Analyses of lung cancer and mediastinal tumor surgery cases in Japan during the COVID-19 pandemic showed no significant disease profile changes related to treatment delay.
DC.rights	This article is licensed under a Creative Commons Attribution 4.0 International License.
DC.format	98913
citation_title	Effects of the COVID-19 pandemic on surgical treatment for thoracic malignant tumor cases in Japan: a national clinical database analysis
citation_author	Shintani, Yasushi
	Yamamoto, Hiroyuki
	Sato, Yukio
	Inoue, Masayoshi
	Asakura, Keisuke
	Ito, Hiroyuki
	Uramoto, Hidetaka
	Okada, Yoshinori
	Sato, Toshihiko
	Fukui, Mariko
	Hoshikawa, Yasushi
	Yoshikawa, Toyofumi Fengshi Chen
	Chida, Masayuki
	Ikeda, Norihiko
	Yoshino, Ichiro
citation_publisher	Springer
citation_language	English
citation_date	2024-12-07
citation_journal_title	Surgery Today
citation_doi	https://doi.org/10.1007/s00595-024-02907-w
citation_public_url	https://hdl.handle.net/11094/98913

Effects of the COVID-19 pandemic on surgical treatment for thoracic malignant tumor cases in Japan: a national clinical database analysis

Link to primary information

Item Information

Show details